Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC
Clinical trial NCT03360630 · COMPLETED
Trial details
- NCT number
- NCT03360630
- Sponsor
- Capital Medical University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2022-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.